Dolby Laboratories Lowers FY2026 GAAP EPS Guidance from $2.71-$2.86 to $2.66-$2.81 vs $2.77 Est

Benzinga Newsdesk www.benzinga.com Negative 96.3%

Neg 96.3% Neu 0% Pos 0%

Dolby Laboratories (NYSE:DLB) lowers FY2026 GAAP EPS guidance from $2.71-$2.86 to $2.66-$2.81 vs $2.77 analyst estimate..